Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog

National Cancer Coalition (DISSOLVED)

CharityWatch report issued
December 2016

CharityWatch Grade
Our independent grade based
on a number of factors.
Program Percentage
Amount spent on programs
relative to overhead.
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

National Cancer Coalition (DISSOLVED)
650 Poydras St
Suite 1400
New Orleans, LA 70130

Other Names

Breast Cancer Relief Foundation

Tax Status


Stated Mission

To meet the unfilled needs of patients and their families impacted by cancer and diseases around the world, thereby reducing the suffering in areas of relief, research, and education.

View similar charities
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund (DISSOLVED)  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Movember Foundation  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 09/30/2015

Program Percentage: 3%

The percentage of National Cancer Coalition (DISSOLVED)'s cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).


Calculated Total Expenses



Cost to Raise $100: $85

How many dollars National Cancer Coalition (DISSOLVED) spends on fundraising to raise each $100 of contributions.


Calculated Total Contributions


Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources


Financial Documents

Entity Document Type Tax ID
The National Cancer Coalition IRS Form 990 76-0435022
The National Cancer Coalition Audited Financial Statements 76-0435022
Entity: The National Cancer Coalition
Document Type: IRS Form 990
Tax ID: 76-0435022
Entity: The National Cancer Coalition
Document Type: Audited Financial Statements
Tax ID: 76-0435022

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
National Cancer Coalition (DISSOLVED)
does not meet governance benchmarks.
National Cancer Coalition (DISSOLVED)
does not meet transparency benchmarks.
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy

Unable to Provide Salaries

CharityWatch is unable to provide a range of Top Three Salaries for this charity for the above fiscal reporting year because we lack complete salary data for the organization. Except for officers, directors, and trustees, the IRS does not require breakouts of salaries totaling less than $100,000.

For example, XYZ charity would be required to provide a breakout in its tax form of compensation to its president of $55,000, but would not be required to provide a breakout of $99,000 in compensation to its top medical researcher if that person is not also an officer, director, or trustee of the organization.

This charity reports that compensation to its officers, directors, and trustees is under $100,000 per individual. Donors who would like to view limited salary data for this organization should refer to its tax form, which may be available on the charity's web site or from a number of third-party sources. See CharityWatch's Links page for information on obtaining copies of charity tax forms.

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to a Final Judgment and Permanent Injunction, dated March 8, 2018, in the matter of The People of the State of California v. The National Cancer Coalition, The National Cancer Coalition (NCC) will be dissolved.

In a complaint filed on March 6, 2018, the California Attorney General alleged that NCC made "false and deceptive representations" related to its "vastly overvalued" in-kind pharmaceutical donations, and that NCC made misrepresentations in its fundraising solicitations about its Breast Cancer Relief Foundation "special project." As stated in the allegations against NCC: "When, as in this case, a charity unlawfully and unfairly includes inflated values for gifts in kind in its public reporting, it appears larger and more efficient than it really is, and thus more attractive to donors." [CharityWatch's treatment of in-kind donations is noted below in the last of the Analysts' Notes listed.]

As part of the Final Judgment, NCC "admits that its use of U.S. market prices in valuing its pharmaceutical donations overseas violated GAAP [Generally Accepted Accounting Principles] and California law because the pharmaceuticals were restricted to use and distribution outside the U.S." One example of NCC's "vastly overvalued" pharmaceutical donation transactions included in the complaint alleges that for a shipment to Nicaragua in 2013, NCC valued the pharmaceuticals Simvastatin and Hydrochlorothiazide at $115,625 (total) using U.S. prices, a value that "was over six times the true fair market value of less than $18,500 using the applicable international prices."

[NOTE: Click on the "Articles & Alerts" tab (above) for a link to the California AG's March 2018 press release about the judgment against National Cancer Coalition.]
According to The National Cancer Coalition (NCC) audit of September 30, 2015 (Note 12, Change in Operating Environment):

"As a result of a material decline in the availability of suitable [donated] pharmaceuticals, NCC incurred a material drop in inventory, revenues and programming. The directors and management recognized these changes and have restructured NCC by reducing salaries and operating expenses. These reductions include the relocation of NCC from Raleigh, North Carolina to New Orleans, Louisiana and major reductions in officer salaries in amount that is expected to be larger than the declines [in] cash funding."

[Note: NCC reported having an unrestricted asset fund balance deficit of -$51,957, according to its audited Statement of Financial Position at September 30, 2015.]
According to The National Cancer Coalition (NCC) tax filing for the fiscal year-ended September 30, 2015, NCC received donated in-kind drugs and medical supplies valued at $552,972 in fiscal 2015 (IRS Form 990 Schedule M).

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

Related External Articles